Oncology Institute Files Proxy Statement for May Meeting
Ticker: TOIIW · Form: DEF 14A · Filed: Mar 27, 2025 · CIK: 1799191
| Field | Detail |
|---|---|
| Company | Oncology Institute, Inc. (TOIIW) |
| Form Type | DEF 14A |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Oncology Institute (TOI) proxy filed for May 7 meeting - shareholders vote on exec pay & board.
AI Summary
The Oncology Institute, Inc. filed a definitive proxy statement (DEF 14A) on March 27, 2025, for its annual meeting on May 7, 2025. The company, formerly known as DFP Healthcare Acquisitions Corp. until January 8, 2020, is seeking shareholder approval for matters related to its corporate governance and operations. The filing details executive compensation, board nominations, and other shareholder proposals.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, executive compensation, and voting matters, allowing them to make informed decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- The Oncology Institute, Inc. (company) — Registrant
- DFP HEALTHCARE ACQUISITIONS CORP. (company) — Former company name
- 20250327 (date) — Filing date
- 20250507 (date) — Meeting date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting on May 7, 2025, including details on executive compensation, board nominations, and other voting matters.
When was The Oncology Institute, Inc. previously known by another name?
The company was formerly known as DFP HEALTHCARE ACQUISITIONS CORP. until January 8, 2020.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on March 27, 2025.
Where is The Oncology Institute, Inc. located?
The company's business and mailing address is 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA 90703.
What is the SIC code for The Oncology Institute, Inc.?
The Standard Industrial Classification code is 8011, which corresponds to SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 27, 2025 regarding Oncology Institute, Inc. (TOIIW).